Stephen Doster
-
Harnessing a key growth pathway to reprogram tumor-associated macrophages
Researchers in the lab of Vivian Weiss, assistant professor of pathology, microbiology, and immunology, recently published a review article in Cancer Research that describes the role of the Wnt pathway in TAMs and tumor biology. Read MoreJan. 3, 2024
-
Jeffrey Spraggins named MSRC director
Jeffrey Spraggins, associate professor of cell and developmental biology, biochemistry, and chemistry, has been named director of the Mass Spectrometry Research Center. He succeeds Richard Caprioli, Stanford Moore Chair in Biochemistry, who established the MSRC in 1998 and who is retiring this summer. Read MoreDec. 24, 2023
-
Call for Proposals: Basic Sciences Pilot Innovation Ignition Fund Program
The School of Medicine Basic Sciences and the Office of the Vice Provost for Research and Innovation launch the Innovation Ignition Fund. This pilot program offers up to $500,000 in funding and drug development mentorship from Vanderbilt scientists with expertise in translational research. Read MoreDec. 18, 2023
-
The Lord of the Rings Leaves it All on the Court
Chuck Sanders, Vice Dean, Vanderbilt School of Medicine Basic Sciences British author J.R.R. Tolkien had a lot to say about the creative process and I’d like to explore how his thoughts relate to the pursuit of cutting-edge scientific research. Tolkien’s The Silmarillion provides both the mythological underpinning… Read MoreDec. 14, 2023
-
Study links gene network and pancreatic beta cell defects to Type 2 diabetes
In a collaborative effort co-led by teams from Vanderbilt University Medical Center (VUMC) and the University of Michigan, a comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. The study, published Dec. 4 in… Read MoreDec. 7, 2023
-
Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial
A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug Discovery has been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical trials—the third WCNDD therapeutic to reach that benchmark. “Vanderbilt is proud that a discovery by our researchers at the Warren Center… Read MoreDec. 4, 2023
-
Vanderbilt Basic Sciences Board of Visitors meeting Dec. 7-8, 2023
Thursday, Dec. 7, 2023 Cocktails and dinner will be at the Butcher and Bee Rose Room at 5:30 p.m. CT. 902 Main St, Nashville, TN 37206 (map) Friday, Dec. 8, 2023 The Board of Visitors meeting will begin at 8:30 a.m. CT. Read MoreDec. 4, 2023
-
Researchers discover key step to kidney fibrosis
Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure. Their discovery, reported Nov. 14 in the journal Nature Communications,… Read MoreNov. 22, 2023
-
The Recipe Box of Life
By Chuck Sanders President-past of the Protein Society The American holiday of Thanksgiving is my favorite. I am guessing that some of my friends from the Great White North share the same opinion about the Canadian version of this feast day, which occurs there in early October. Taking… Read MoreNov. 21, 2023
-
Opera meets neuroscience: Vanderbilt’s Lisa Monteggia discusses the science of Nashville Opera’s ‘The Man Who Mistook His Wife for a Hat’
On Nov. 2, Lisa Monteggia, Barlow Family Director of the Vanderbilt Brain Institute and professor of pharmacology, psychiatry and psychology, joined John Hoomes, CEO and artistic director of the Nashville Opera, for a discussion on the artistic approach and scientific research behind the Nashville Opera’s upcoming performance of The Man Who Mistook His Wife for a Hat. Read MoreNov. 9, 2023